Buying above a ten pack: what actually changes.

Retatrutide and Tirzepatide have published packs up to 100 vials. Every other compound is published to the ten pack, and past it the number moves. Here is why, and how to ask.

The floor is public, and that is the point

Every price this business publishes is open to anyone. The pack pricing page has single vials, five packs and ten packs for the whole catalogue, with the peso per milligram worked out at the ten pack.

Two compounds go further. Retatrutide 20mg and Tirzepatide 15mg have published 25, 50 and 100 vial packs, sold from the product page like any other pack: Retatrutide 20mg from ₱950 a vial at 100 and Tirzepatide 15mg from ₱750 a vial at 100. The full ladder is in the published bulk tiers.

There is no conversation to have first, no account to open and nothing to qualify for. A buyer who has never sent a message pays exactly what a buyer of two years pays. If a published pack is the right unit for what you are doing, you already have the number and there is nothing underneath it to ask for. Everything below is about every other compound past the ten pack, not about a hidden tier beneath a published one.

What actually changes above a pack

For every compound except Retatrutide and Tirzepatide, twenty, fifty or a hundred vials of one compound stops being a catalogue transaction, and the reason is upstream rather than anything to do with generosity.

Our own supplier prices differently at those volumes. That is the mechanism, and it is the whole mechanism. When the cost of goods moves, the number can move, and what gets passed through is the movement upstream rather than a margin we decided to give up because someone asked nicely.

This is worth being precise about, because it explains something that otherwise looks arbitrary. Asking for a discount on a ten pack gets an honest no, because nothing upstream has changed at that quantity. Asking about a hundred vials of one compound gets a real number, because something upstream has.

Why only two compounds have published bulk tiers

Retatrutide and Tirzepatide move at enough volume, at every order size, to price publicly, so their 25, 50 and 100 vial packs are printed and bought like any other pack.

For the rest of the catalogue it is not one number. It moves with the compound, because the upstream cost structure is not uniform across the catalogue. It moves with the quantity, in a way that is not linear. And it moves with whether you are ordering once or every month, because a predictable standing order lets stock be held against it and a one-off does not. A single printed figure for those compounds would be wrong for most people reading it, so it is quoted against the order.

What moves it, in order of how much

Consistency moves it most. A steady monthly order is worth more than a larger one-off, because it allows stock to be held against a known run rate rather than guessed at. This is the lever people expect least and it is the strongest one.

Volume per order moves it next, which is the obvious one and is genuinely the second most important rather than the first.

Compound mix moves it too. There is more room in some compounds than others, so a mixed order sometimes prices better than the same total value concentrated in a single product.

What does not move it: asking twice, mentioning a competitor's quote, or opening with a target price. None of those change what anything costs upstream, and the reply will be the same number it would have been anyway.

What you get besides a number

Above a pack, price is usually not the thing that ends up mattering most, which is not what people expect when they start the conversation.

Allocation is stock held against your run rate, so a compound you rely on is not competing with retail demand for the last vials on the shelf. For anyone whose business depends on being able to say yes, that is worth more than a price movement, because running out has a cost that does not appear on any invoice.

Sourcing outside the catalogue is the other one. Seventeen compounds are stocked and the sourcing route is wider than the list, so something not on the shelf is often gettable. Standing accounts also hear about new stock before the site updates.

The kit stays: consumables ship with every order at every size. Up to the 25 pack every vial ships with its own kit; the 50 and 100 packs ship with 10 kits and 10 BAC waters by default, and more kits are free on request. Detail on reseller supply and clinic and med spa supply.

How to ask so you get a real answer

Send the compound, the actual quantity, and how often you would reorder. Those three things are enough to answer properly in one reply rather than three rounds of questions.

Send the volume you are genuinely considering rather than the one you are aspiring to. A quote against an invented number is worthless to both sides: it produces a figure you cannot actually transact on, and an allocation that is wrong.

You will get a number rather than a range, and if the volume you named does not move the price off the published pack tier, you will be told that instead of being given a reason it should. That is a more useful answer than a manufactured discount, and it is the one most first enquiries get.

When the honest answer is to just buy the pack

Most people reading this should buy a published pack and stop there: the ten pack on most compounds, and up to the 100 pack on Retatrutide and Tirzepatide.

If a published pack covers what you move, it is already our best number for it and an account adds nothing except a conversation. Being told that is the normal outcome of a first enquiry, and it is a better outcome than opening an account that does nothing for you.

The threshold is not a secret and it is not a test. It is simply the point where the upstream cost structure changes, and below it there is nothing to pass through. The pack pricing page and the published bulk tiers have every published tier, and the numbers there are real, current and generated from the catalogue rather than typed into copy.

Supplied for laboratory research use only. Not for human consumption. Nothing on this page is medical advice.

Questions

Is there better pricing above ten vials of one compound?

Yes. Retatrutide 20mg and Tirzepatide 15mg have published 25, 50 and 100 vial packs on their product pages, open to anyone. For every other compound, above a ten pack our own supplier prices deeper and that is passed through, quoted against the actual order because it moves with the compound, the quantity and the reorder frequency.

Why is the above-pack price published for only two compounds?

Retatrutide and Tirzepatide move at enough volume to price publicly. For the rest it is not one number: it moves with compound, quantity and consistency, so any single published figure would be wrong for most people reading it.

What is the minimum order to get a better price?

There is no published minimum. The published bulk tiers on Retatrutide and Tirzepatide start at 25 vials, no account needed. For other compounds, consistency moves the number more than volume per order does, so a steady monthly order is worth more than a large one-off. Send the volume you are actually considering and you get a real answer.

Can I negotiate on a ten pack?

No. Nothing changes upstream at that quantity, so the published tier is the floor and there is nothing underneath it. Volume above a pack is a different conversation because the cost of goods genuinely moves there.